These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 22352257

  • 1. [Treatment research of intermediate severity depression: what is useful for the routine patient?].
    MMW Fortschr Med; 2012 Feb 09; 154(2):69. PubMed ID: 22352257
    [No Abstract] [Full Text] [Related]

  • 2. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A, Schmidt M, Hauke W, Stade K.
    Phytomedicine; 2011 Jun 15; 18(8-9):739-42. PubMed ID: 21514125
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
    Möller HJ, Langer S, Schmauss M.
    Pharmacopsychiatry; 2007 Mar 15; 40(2):53-7. PubMed ID: 17447173
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM, Azorin JM, Despiegel N, Verpillat P.
    Int J Clin Pract; 2005 Mar 15; 59(3):268-75. PubMed ID: 15857321
    [Abstract] [Full Text] [Related]

  • 5. [A trial of treating depressive states with cipramil].
    Iakovlev VA, Belinskiĭ AV, Dorovskikh IV.
    Voen Med Zh; 2000 Jun 15; 321(6):53-6. PubMed ID: 10929517
    [No Abstract] [Full Text] [Related]

  • 6. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
    Landowski J.
    Psychiatr Pol; 2000 Jun 15; 34(3 Suppl):1-8. PubMed ID: 11055187
    [Abstract] [Full Text] [Related]

  • 7. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
    Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR.
    Med Care; 2007 Nov 15; 45(11):1043-51. PubMed ID: 18049344
    [Abstract] [Full Text] [Related]

  • 8. Lack of desipramine toxicity with citalopram.
    Ashton AK.
    J Clin Psychiatry; 2000 Feb 15; 61(2):144. PubMed ID: 10732663
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR.
    Drug Alcohol Depend; 2009 Jan 01; 99(1-3):248-60. PubMed ID: 18986774
    [Abstract] [Full Text] [Related]

  • 10. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
    Rao V, Spiro JR, Rosenberg PB, Lee HB, Rosenblatt A, Lyketsos CG.
    Int J Geriatr Psychiatry; 2006 Mar 01; 21(3):273-4. PubMed ID: 16477587
    [Abstract] [Full Text] [Related]

  • 11. Clinical development of citalopram.
    Willetts J, Lippa A, Beer B.
    J Clin Psychopharmacol; 1999 Oct 01; 19(5 Suppl 1):36S-46S. PubMed ID: 10507507
    [No Abstract] [Full Text] [Related]

  • 12. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T, Ising M, Erbe S, Winkelmann P, Ritter D, Uhr M, Lewitzka U.
    J Psychiatr Res; 2012 Jan 01; 46(1):111-7. PubMed ID: 22030468
    [Abstract] [Full Text] [Related]

  • 13. Diurnal mood variation in outpatients with major depressive disorder.
    Morris DW, Trivedi MH, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Jain S, Rush AJ.
    Depress Anxiety; 2009 Jan 01; 26(9):851-63. PubMed ID: 19306304
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S.
    Psychiatry Res; 2009 Sep 30; 169(2):132-8. PubMed ID: 19709754
    [Abstract] [Full Text] [Related]

  • 15. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME, Baker B, Frasure-Smith N, Swenson JR, Koszycki D, Butler G, van Zyl LT, Lespérance F.
    J Psychosom Res; 2010 Aug 30; 69(2):133-41. PubMed ID: 20624511
    [Abstract] [Full Text] [Related]

  • 16. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.
    Linka T, Müller BW, Bender S, Sartory G.
    Neurosci Lett; 2004 Sep 09; 367(3):375-8. PubMed ID: 15337269
    [Abstract] [Full Text] [Related]

  • 17. Use of escitalopram in psychogenic excoriation.
    Pukadan D, Antony J, Mohandas E, Cyriac M, Smith G, Elias A.
    Aust N Z J Psychiatry; 2008 May 09; 42(5):435-6. PubMed ID: 18499934
    [No Abstract] [Full Text] [Related]

  • 18. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
    Zobel AW, Schulze-Rauschenbach S, von Widdern OC, Metten M, Freymann N, Grasmäder K, Pfeiffer U, Schnell S, Wagner M, Maier W.
    J Psychiatr Res; 2004 May 09; 38(4):377-83. PubMed ID: 15203289
    [Abstract] [Full Text] [Related]

  • 19. A surveillance study of escitalopram treatment of depressed patients.
    Anders M, Tuma I, Rösslerova H.
    Expert Opin Pharmacother; 2008 Jan 09; 9(1):1-6. PubMed ID: 18076333
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ.
    Biol Psychiatry; 2005 Dec 01; 58(11):865-70. PubMed ID: 15993860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.